Adequate protein intake (1.2-1.6 g/kg ideal body weight daily) helps preserve lean muscle mass during weight loss, which is crucial for maintaining metabolic rate
Algunos estudios observacionales han explorado si los pacientes con diabetes u obesidad que usan agonistas de GLP-1 tienen diferentes tasas de ciertos cnceres, pero estos anlisis estn confundidos por mltiples factores, incluyendo el hecho de que la obesidad y la diabetes mismas son factores de riesgo independientes para varios tipos de cncer
Meanwhile, FGFR2c/3c activation in hepatocytes inhibits de novo lipogenesis and limits lipid accumulation
Storage (reconstituted): After reconstitution, refrigerate at 2C to 8C and use within 2030 days
Based on our data, we propose that T3 has a regulatory role in insulin-controlled glucose metabolism, and T3 exerts this function by increasing non-12-OH FXR-antagonistic BA levels via downregulating the expression of CYP8B1, which potentiates GLP-1 production via suppressing the intestinal FXR signaling
Eli Lilly is running a direct head-to-head trial comparing the two drugs (NCT06662383, 800 patients)